Categories
Uncategorized

Asahi Kasei Medical acquires Austrian ViruSure Forschung und Entwicklung GmbH

by Gerhard Fasol (31 October 2019)

Asahi Kasei Medical announced the acquisition of Austrian contract research firm ViruSure Forschung und Entwicklung GmbH based in Vienna (Austria).

ViruSure Forschung und Entwicklung GmbH

  • Operations Director: Dr Andrew C Bailey,
  • Finance and Administration Director: Dr Alexander Vodopivec
  • Team members: approx 45 (as of Sept 2018)
  • Investors: PP Capital AG
  • http://www.virusure.com

Asahi Kasei Medical KK (旭化成メディカル株式会社)

Business divisions

  • Dialysis: global leader driving progress in dialysis therapy
  • Therapeutic Aphaeresis: making therapeutic aphaeresis available worldwide to expand treatment options and possibilities
  • Blood transfusion: reducing blood transfusion risk and heightening trust in healthcare
  • Bio-processes: expanding availability of high-quality drugs by enhancing safety in biopharmaceutical production

Copyright 2019 Eurotechnology Japan KK. All Rights Reserved.